The article in the latest issue of Fette Compacting’s customer magazine “What’s Next” provides an insightful overview of the development of a component, a sinker (placebo tablet) to increase the weight of a capsule, EsoCap’s novel platform technology for the world’s first local treatment of the oesophagus. The article shows that the collaboration between EsoCap and Fette Compacting not only developed a sinker, but also improved the swallowability of the capsule to ensure easy and reliable application.
With a view to later production, a design was also found that could be easily and efficiently implemented on the machine. “Our vision is to improve the lives of patients with severe oesophageal diseases through targeted, easy-to-use, local and long-lasting treatments,” says Dr Peter Stangier, Director of Strategic Planning at EsoCap. “We have developed a unique form of administration for this purpose.”
Read full “What’s Next” issue – Fette Compacting Magazine 2024/1
